Prospects of etiopathogenetic treatment of Huntington’s disease
Open Access
- 25 March 2023
- journal article
- research article
- Published by Publishing House ABV Press in Neuromuscular Diseases
- Vol. 13 (1) , 22-32
Abstract
Huntington’s disease is a serious inherited neurodegenerative disorder characterized by of motor, cognitive and psychiatric features. The disease is caused by an abnormally expanded CAG repeat expansion in the HTT gene and the production of mutant huntingtin protein.The disease usually manifests in adulthood, but the manifestation in childhood and youth is also described, which is noted in 5–10 % of cases. The disease predominantly affects the neostriatum, resulting in a characteristic clinical picture.The most promising approaches to etiotropic therapy of Huntington’s disease are a number of DNA- (CRISPR/Cas9 system) and RNA-directed methods (antisense oligonucleotides, RNA interference), methods that directly reduce the level of mutant gentingtin (chimera molecules), as well as approaches based on inactivating the DNA mismatch repair system using the FAN1 enzyme.Keywords
This publication has 22 references indexed in Scilit:
- Recent Advances in the Treatment of Huntington’s Disease: Targeting DNA and RNACNS Drugs, 2020
- Therapeutic Advances for Huntington’s DiseaseBrain Sciences, 2020
- CTIP2-Regulated Reduction in PKA-Dependent DARPP32 Phosphorylation in Human Medium Spiny Neurons: Implications for Huntington DiseaseStem Cell Reports, 2019
- Huntingtin Lowering Strategies for Disease Modification in Huntington’s DiseaseNeuron, 2019
- CRISPR/Cas9-Mediated Genome Editing for Huntington’s Disease2018
- Proteostasis in Huntington's disease: disease mechanisms and therapeutic opportunitiesActa Pharmacologica Sinica, 2018
- Precise Excision of the CAG Tract from the Huntingtin Gene by Cas9 NickasesFrontiers in Neuroscience, 2018
- CRISPR-Cas9 Mediated Gene-Silencing of the Mutant Huntingtin Gene in an In Vitro Model of Huntington’s DiseaseInternational Journal of Molecular Sciences, 2017
- Early detection of Huntington‘s diseaseFuture Neurology, 2009
- Five siRNAs Targeting Three SNPs May Provide Therapy for Three-Quarters of Huntington's Disease PatientsCurrent Biology, 2009